Zimmer Biomet Exceeds Expectations with Second Quarter Performance

Zimmer Biomet reported 2Q22 orthopedic sales of $1.8 billion, +1% vs. 2Q21. The company exceeded its internal expectations for the quarter, citing COVID recovery and execution across the company's regions and segments.

Against weaker comparisons from 2Q21, Zimmer Biomet drove double-digit growth in markets outside the U.S. despite COVID...

document icon

You’ve reached your limit.

We’re glad you’re finding value in our content — and we’d love for you to keep going.

Subscribe now for unlimited access to orthopedic business intelligence.

ME

Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.



Contact Us

0